- |||||||||| ivermectin oral / Generic mfg.
Clinical, Review, Journal: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article. (Pubmed Central) - Jun 16, 2021 This evidence-based review article aims to discuss the mechanism of action of ivermectin against SARS-CoV-2 and summarizing the available literature over the years. A schematic of the key cellular and biomolecular interactions between Ivermectin, host cell, and SARS-CoV-2 in COVID-19 pathogenesis and prevention of complications have been proposed.
- |||||||||| moxidectin / Generic mfg., ivermectin oral / Generic mfg.
Journal: Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis. (Pubmed Central) - Jun 12, 2021 Prophylaxis of onchocerciasis is not a new concept. We present new data showing that these drugs can inhibit L3 molting and/or inhibit motility of L4 at IC50 and IC90 that are covered by the concentration of these drugs in plasma based on the corresponding pharmacological profiles obtained in human clinical trials when these drugs were tested using various doses for the therapeutic treatments of various helminth infections.
- |||||||||| chloroquine phosphate / Generic mfg., hydroxychloroquine / Generic mfg., ivermectin oral / Generic mfg.
Clinical, P2 data, Journal: Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection. (Pubmed Central) - Jun 12, 2021 To be older than 60 years of age, obesity, diabetes, extensive pulmonary involvement and low SaO at hospital admission due to independent risk factors for mortality. Although CQ, HCQ or ivermectin revealed a favorable safety profile, the tested drugs do not reduce the need for supplemental oxygen, ICU admission, invasive ventilation or death, in patients hospitalized with a severe form of COVID-19.
- |||||||||| ivermectin oral / Generic mfg.
Review, Journal: Ivermectin gegen Hakenwurm - und Coronavirus? (Pubmed Central) - Jun 11, 2021 However, larger-scale trials are warranted for this conclusion to be further cemented. No abstract available
- |||||||||| ivermectin oral / Generic mfg.
PK/PD data, Journal: The effect of food on the pharmacokinetics of oral ivermectin. (Pubmed Central) - Jun 10, 2021 No abstract available In this analysis, the effect of a high-fat breakfast compared with a fasted-state administration of a single oral dose of 12 mg ivermectin was minimal.
- |||||||||| ivermectin oral / Generic mfg.
Journal: Scabies. (Pubmed Central) - Jun 10, 2021 Repeated therapeutic failure when permethrin was used under controlled conditions and documented mechanisms for increased tolerance may indicate the last possibility. We therefore call for additional research on this topic.
- |||||||||| Veramyst (fluticasone furoate nasal spray) / GSK
Enrollment open: ACTIV-6: COVID-19 Study of Repurposed Medications (clinicaltrials.gov) - Jun 10, 2021 P3, N=15000, Recruiting, Moxidectin, another macrocyclic lactone, with a longer plasma half-life, could be considered too. Not yet recruiting --> Recruiting
- |||||||||| Actemra IV (tocilizumab) / Roche, JW Pharma, Soliris (eculizumab) / Alexion Pharma
Biomarker, Clinical, Review, Journal: Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs. (Pubmed Central) - Jun 9, 2021 These drugs include chloroquine (CQ), hydroxychloroquine (HCQ), azithromycin, lopinavir/ritonavir (LPV/r), atazanavir (ATV), favipiravir (FVP), nevirapine (NVP), efavirenz (EFV), oseltamivir, remdesivir, anakinra, tocilizumab (TCZ), eculizumab, heme oxygenase 1 (HO-1) regulators, renin-angiotensin-aldosterone system (RAAS) inhibitors, ivermectin, and nitazoxanide...The major drug variant pairs that associated with variations in clinical efficacy include CQ/HCQ (CYP2C8, CYP2D6, ACE2, and HO-1); azithromycin (ABCB1); LPV/r (SLCO1B1, ABCB1, ABCC2 and CYP3A); NVP (ABCC10); oseltamivir (CES1 and ABCB1); remdesivir (CYP2C8, CYP2D6, CYP3A4, and OATP1B1); anakinra (IL-1a); and TCZ (IL6R and FCGR3A). The major drug variant pairs that associated with variations in adverse effects include CQ/HCQ (G6PD; hemolysis and ABCA4; retinopathy), ATV (MDR1 and UGT1A1*28; hyperbilirubinemia; and APOA5; dyslipidemia), NVP (HLA-DRB1*01, HLA-B*3505 and CYP2B6; skin rash and MDR1; hepatotoxicity), and EFV (CYP2B6; depression and suicidal tendencies).
- |||||||||| ivermectin oral / Generic mfg.
Journal: Ivermectin as a potential treatment for COVID-19? (Pubmed Central) - Jun 9, 2021 Thus, this in vitro system may provide a platform to investigate mating behaviour and early stage of nodulogenesis of O. volvulus adult worms that can be used as additional targets for macrofilaricidal drug screening. No abstract available
|